AVIR

Atea Pharmaceuticals, Inc. - common stock (AVIR)

About Atea Pharmaceuticals, Inc. - common stock (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$3.32

Daily low

$3.18

Price at open

$3.20

52 Week High

$4.14

52 Week Low

$2.46

Market cap

274.7M

Dividend yield

0.00%

Volume

369,295

Avg. volume

394,871

P/E ratio

-1.95

Atea Pharmaceuticals, Inc. - common stock News